Search Results

Displaying Results 2826-2850 of 28063 "'FORM'"

Aug 04, 2026, 16:05 ET Teradata Reports Second Quarter 2026 Financial Results

Company believes this is a useful metric to investors as it demonstrates progress toward achieving our strategic objectives as outlined in the Form 10-K and Form 10-Q.**Public cloud ARR is defined as the annual contract value for

More news about: Teradata


Aug 04, 2026, 16:05 ET Flotek Increases 2026 Guidance as Data Analytics Delivers Record Quarterly Revenue

and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K and Form 10-Q (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents.

More news about: Flotek Industries, Inc.


Aug 04, 2026, 16:05 ET Lucid Announces Operational Reset and Second Quarter 2026 Results

factors discussed under the cautionary language and the Risk Factors in Lucid's Annual Report on Form 10-K for the year ended December 31, 2025, subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other documents Lucid has filed or will file with the Securities and Exchange Commission.

More news about: Lucid Group


Aug 04, 2026, 16:05 ET Compass, Inc. Reports Record Second Quarter 2026 Results

call transactions we entered into in connection with the Convertible Notes; and other risks set forth in our annual report on Form 10-K and our subsequent quarterly reports on Form 10-Q. Significant variation from the assumptions underlying our forward-looking statements could cause our actual results to

More news about: Compass, Inc.


Aug 04, 2026, 16:05 ET Qualys Announces Second Quarter 2026 Financial Results

uncertainties, including those more fully described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.The forward-looking statements in this press release are based on information available to Qualys as of the date hereof,

More news about: Qualys, Inc.


Aug 04, 2026, 16:05 ET DaVita Inc. 2nd Quarter 2026 Results

andthe other risk factors, trends and uncertainties set forth in our Annual Report on Form 10-K for the year ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, and the risks and uncertainties discussed in any subsequent reports that

More news about: DaVita


Aug 04, 2026, 16:05 ET Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights

described in our prior filings with the Securities and Exchange Commission (SEC), including under the heading "Risk Factors" in our annual report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as

More news about: Tyra Biosciences


Aug 04, 2026, 16:05 ET Mercury General Corporation Announces Second Quarter Results and Declares Quarterly Dividend

events or otherwise. For a more detailed discussion of some of the foregoing risks and uncertainties, see the Company's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on February 17, 2026.

More news about: Mercury General Corporation


Aug 04, 2026, 16:05 ET Emerson Reports Third Quarter 2026 Results; Raises 2026 Outlook

property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company's expectation for its consolidated results, other

More news about: Emerson


Aug 04, 2026, 16:03 ET Revolve Group Announces Second Quarter 2026 Financial Results

with the Securities and Exchange Commission, or SEC, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2025, and our subsequent Quarterly Reports on Form 10-Q, including for the quarter ended June 30, 2026, which we expect to file with the SEC on August 4, 2026.

More news about: Revolve Group, Inc.


Aug 04, 2026, 16:01 ET G. WILLI-FOOD INTERNATIONAL ANNOUNCES DELISTING FROM NASDAQ AND CONCENTRATION OF ITS SHARE TRADING ON THE TEL AVIV STOCK EXCHANGE

result of the Company concentrating its share trading on a single exchange.The Company anticipates that it will file with the SEC a Form 25 relating to the delisting of its Ordinary Shares from trade on NASDAQ on or about August 17, 2026. As a result, the Company expects that the last

More news about: G. Willi-Food International Ltd.


Aug 04, 2026, 16:01 ET Atomera Provides Second Quarter 2026 Results

proprietary technology, trade secrets and know-­how and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake,

More news about: Atomera Incorporated


Aug 04, 2026, 16:01 ET Red Rock Resorts Announces Second Quarter 2026 Results

customers, employees, suppliers and business partners; and other risks discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in the Company's other current and periodic reports filed from time to time with the Securities

More news about: Red Rock Resorts, Inc.


Aug 04, 2026, 16:01 ET AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does

More news about: Amgen


Aug 04, 2026, 16:01 ET Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth

differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.Investor Contact:Steven M. HarasymTel:

More news about: Precigen, Inc.


Aug 04, 2026, 16:01 ET Rigel Reports Second Quarter 2026 Financial Results

well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 and subsequent filings. Any forward-looking statement made by us in this press release is based only on information

More news about: Rigel Pharmaceuticals, Inc.


Aug 04, 2026, 16:01 ET Wynn Resorts, Limited Reports Second Quarter 2026 Results

Additional information concerning potential factors that could affect the Company's financial results is included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, as supplemented by the Company's other periodic reports filed with the Securities and Exchange Commission

More news about: Wynn Resorts, Limited


Aug 04, 2026, 15:30 ET Elong Power Holding Limited Announces Closing of US$1.38 Million Public Offering

Cashman LLP acted as U.S. securities counsel to the placement agent, in connection with the Offering.The Company's Registration Statement on Form F-1 (File No. 333-297612) was filed with the U.S. Securities and Exchange Commission (SEC) and declared effective on July 28, 2026. The Offering was

More news about: Elong Power Holding Limited


Aug 04, 2026, 15:28 ET Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

described in Lunai Bioworks' filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Lunai Bioworks undertakes no obligation to update forward-looking statements except as required by law.

More news about: Lunai Bioworks Inc.


Aug 04, 2026, 15:06 ET NNS erwirbt Anteile an OCI

börsennotierte und nicht börsennotierte Aktien, Kreditinstrumente und Immobilien umfasst, und geht zudem Partnerschaften mit externen Investoren in Form von Joint Ventures ein. NNS ist der größte Anteilseigner von OCI.Alle Pressemitteilungen und sonstigen Dokumente im Zusammenhang mit dem Angebot

More news about: NNS Holding (Cyprus) Limited


Aug 04, 2026, 15:03 ET BigID Defines the Missing Governance Layer for Autonomous AI Agents

accessTraces the full chain of what an agent read, moved, or acted on, tied directly to the sensitivity of the data involvedTogether, they form what BigID calls an authority layer: one system of record for what an agent is allowed to do, what it says it's trying to do, and what it's actually

More news about: BigID


Aug 04, 2026, 14:35 ET JMD Creative Agency Marks 10 Years with a Bold New Chapter: A Rebrand, Strategic Partnership, Two Senior Appointments

strategic thinking behind a brand's growth. The agency has also expanded its industrial design capabilities and team, sharpening its focus on product form, structure, and function alongside its packaging and identity work.To lead this expansion, JMD has named two senior leaders:Leslie

More news about: JMD


Aug 04, 2026, 13:47 ET The AI Buildout Runs on Power and Cooling. Bitzero Just Deepened Its Bench With Vertiv.

catches on. Eagle Eye is a real-time investor signal-intelligence platform that surfaces sentiment shifts, news flow, and trending tickers as they form, so you see attention building instead of chasing it. Watch it live at eagle-eye.dev.Article

More news about: USA News Group


Aug 04, 2026, 13:33 ET The Infrastructure Under America's Busiest Spaceport Was Built for Another Era. New Legislation Would Let Private Companies Help Modernize It.

catches on. Eagle Eye is a real-time investor signal-intelligence platform that surfaces sentiment shifts, news flow, and trending tickers as they form, so you see attention building instead of chasing it. Watch it live at eagle-eye.dev.Article

More news about: USA News Group


Aug 04, 2026, 12:53 ET Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders?

options.AtaiBeckley Inc. (NASDAQ: ATAI)'s sale to Eli Lilly and Company for $6.75 per share in cash, plus up to $2.50 per share in the form of a Contingent Value Right entitling the holder to additional cash payments upon achievement of specified development and regulatory milestones related

More news about: Halper Sadeh LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.